CENTURY THERAPEUTICS INC (IPSC) Stock Analyst Ratings
USA - NASDAQ:IPSC - US15673T1007 - Common Stock
0.4723 USD
+0.01 (+1.68%)
0.4576 USD
-0.01 (-3.11%)
ChartMill assigns a Buy % Consensus number of 84% to IPSC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 979.82% above the current price.
IPSC was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about IPSC.
In the previous month the buy percentage consensus was at a similar level.
IPSC was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-16 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-28 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-03-24 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-21 | Guggenheim | Maintains | Buy -> Buy |
| 2025-03-20 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-01-22 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-01-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-30 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-11-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-17 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-06-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-12 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-03-15 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-28 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2023-08-10 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-08-10 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-08-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-17 | EF Hutton | Maintains | Buy |
| 2023-04-13 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-22 | Chardan Capital | Reiterate | Buy |
| 2023-03-17 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-16 | EF Hutton | Reiterate | Buy |
CENTURY THERAPEUTICS INC / IPSC FAQ
What is the price target for IPSC stock?
11 analysts have analysed IPSC and the average price target is 5.1 USD. This implies a price increase of 979.82% is expected in the next year compared to the current price of 0.4723.
What is the consensus rating for IPSC stock?
The consensus rating for CENTURY THERAPEUTICS INC (IPSC) is 83.6364 / 100 . This indicates that analysts generally have a positive outlook on the stock.